Product Information
CYCLOSPORINE MODIFIED 100 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.2499 per EA under NDC 00093902065. Its NADAC has been published 265 times since Jul 28, 2021.
FDA first approved this application on Mar 29, 2005. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093902065
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CYCLOSPORINEApproval Type
Generic (ANDA)
FDA Application
ANDA065110FDA Approved
3/29/2005
TE Code
AB1
On Market Since
6/8/2021
Pharmacological Classes
Price Statistics
The NADAC for CYCLOSPORINE MODIFIED 100 MG has been published 265 times since Jul 28, 2021, and over the history we have for it it has declined 41.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2499 per EA |
|---|---|
| All-time high | $2.4440 (Aug 14, 2024) |
| All-time low | $1.2257 (Mar 18, 2026) |
| 52-week high | $1.7564 |
| 52-week low | $1.2257 |
| Median price | $1.5094 |
| Average price | $1.5793 |
| Largest weekly change | +45.7% (Jul 17, 2024) |
| Weeks tracked | 265 |
| Tracking since | Jul 28, 2021 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOSPORINE MODIFIED 100 MG?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOSPORINE MODIFIED 100 MG, manufactured by Teva Pharmaceuticals USA Inc., is $1.2499 per EA (NDC 00093902065), effective Aug 19, 2026.
How has the price of CYCLOSPORINE MODIFIED 100 MG changed over time?
Over the history we have for it, the NADAC for CYCLOSPORINE MODIFIED 100 MG has declined 41.3%. It has been tracked across 265 weekly CMS publications since Jul 28, 2021.
What are the highest and lowest recorded NADAC prices for CYCLOSPORINE MODIFIED 100 MG?
Since Jul 28, 2021, the NADAC for CYCLOSPORINE MODIFIED 100 MG has ranged from a low of $1.2257 (Mar 18, 2026) to a high of $2.4440 (Aug 14, 2024), with a median of $1.5094 per EA.
Are there cheaper alternatives to CYCLOSPORINE MODIFIED 100 MG?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOSPORINE MODIFIED 100 MG, is $1.2400 per EA — about 1% below CYCLOSPORINE MODIFIED 100 MG.
Who manufactures CYCLOSPORINE MODIFIED 100 MG?
CYCLOSPORINE MODIFIED 100 MG (NDC 00093902065) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.